熱門資訊> 正文
Lantheus退出，重新提交HSR收购Curium的申请
2026-09-22 05:35
- Lantheus Holdings (LNTH) said it has withdrawn and refiled its Hart-Scott-Rodino (HSR) Act pre-merger notification regarding its $8B acquisition of Curium.
- The withdrawal, done on Sept. 17, was done "to provide the Federal Trade Commission (the “FTC”) with additional time to review the Merger," per an SEC filing.
- The resubmission was filed on Monday, meaning the standard HSR 30-day waiting period will end on Oct. 21 at 11:59 p.m.
- Lantheus said that a refiling is “routine procedure” for antitrust review and still expects the merger to close in H1 2027.
More on Lantheus Holdings
- Lantheus Holdings: Why I Am Exiting Before The Merger Closes
- Novartis' Lutathera now facing generic competition from Curium's Bexlutry
- Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s
- Seeking Alpha’s Quant Rating on Lantheus Holdings
- Historical earnings data for Lantheus Holdings
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
